Al's Comment:

 This is a must see by anyone involved with brain tumors. DCVAX is an experimental vaccine therapy. The results of the phase 3 trial were published recently Excellent results in newly diagnosed as well as recurrent GBM. Dr Liau is the co-inventor of the vaccine and ran the clinical trial.  As always, our webinars are free, however donations are appreciated. If you make a donation (by clicking the DONATE button on the webinar page), mention in the comment you want the donation to be used for vaccines only and we will use 100% of your donation to help speed up the approval of vaccine therapies.

Posted on: 11/21/2022

DCVAX Webinar 

Monday Dec 5, 2022 at 8:30 PM Eastern:

Speaker: Linda Liau, MD, PhD, MBA - the chair of the dept of neurosurgery at UCLA, and Professor and Director of the UCLA Brain Tumor Program. Dr. Liau's clinical expertise is in intra-operative functional brain mapping and use of intra-operative imaging for resection of brain tumors (gliomas, meningiomas, and metastatic tumors). Her research efforts are focused on the molecular biology of brain tumors, gene therapy, immunotherapy, and brain cancer vaccines. Dr. Liau is the former Editor-in-Chief of the Journal of Neuro-Oncology.
Go to a few miutes before the webinar starts. No advance registration needed. 


Click HERE to return to brain tumor news headlines.

Our privacy / cookie policy has changed.
Click HERE to read it!